Showing results (901-910 of 2,938) with videos related to
Sort By:
Pageof 294
Cancer Investigation|January 1, 1984
Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activityE J Pavlik, D E Kenady, J R van Nagell, et al.Cancer Investigation|May 12, 2021
LncRNA LINC00958 Activates mTORC1/P70S6K Signalling Pathway to Promote Epithelial-Mesenchymal Transition Process in the Hepatocellular CarcinomaChuangxia Lan, Yanming Wang, Xiaofei Su, et al.Cancer Investigation|August 4, 2021
Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma PatientsNadia ElMenshawy, Nora A Farag, Doaa M Atia, et al.Cancer Investigation|June 17, 1999
Narrowing the options: the process of deciding on prostate cancer treatmentM E O'RourkeCancer Investigation|April 1, 1999
Prolonged severe 5-fluorouracil-associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiencyN Shehata, A Pater, S C TangCancer Investigation|April 9, 2001
Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patientsS Cascinu, E Del Ferro, M Ligi, et al.Cancer Investigation|April 9, 2001
Quality improvement efforts in oncology: are we ready to begin?C L Bennett, J M Crane, Cancer Investigation|April 12, 2001
Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from GermanyC L Bennett, D Lane, T Stinson, et al.Cancer Investigation|April 12, 2001
Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extractsH J Gabius, F Darro, M Remmelink, et al.Cancer Investigation|April 12, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancerE Razis, A M Dimopoulos, D Bafaloukos, et al.Pageof 294